Nonalcoholic Fatty Liver Disease, Cardiovascular Risk, and Carotid Inflammation
Open Access
- 6 November 2014
- journal article
- editorial
- Published by SAGE Publications in Angiology
- Vol. 66 (7), 601-603
- https://doi.org/10.1177/0003319714557353
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic ApproachesNutrients, 2013
- Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists?Journal of Obesity, 2012
- Fatty Liver: A Link to Cardiovascular Disease – Its Natural History, Pathogenesis, and TreatmentMethodist DeBakey Cardiovascular J, 2012
- Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatographyClinical Biochemistry, 2012
- Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?Clinica Chimica Acta; International Journal of Clinical Chemistry, 2011
- Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?Diabetes Care, 2008
- GI Epidemiology: nonalcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 2007
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisJournal of Hepatology, 2006
- Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic PatientsDiabetes, 2005
- Nonalcoholic Fatty Liver Disease Is Associated With Carotid AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005